19 Mar 340B Reform Discussion Continues
HHS Secretary Alex Azar provided comment to the National Association of Community Health Centers that Medicare’s regulation to cut reimbursement for 340B drugs exemplifies transparency and fairness in drug pricing. He said, “The program was intended to offer affordable medicines to providers focused on low-income Americans, but has now expanded far beyond the original set of providers identified.” He said the program is an “immensely valuable tool” for community health centers, which serve low-income patients and HHS is “committed to ensuring the benefits of the program flow to its intended recipients — and that means the patients that you serve.”
The Senate HELP Committee held a 340B hearing last week, laying the groundwork for the Senate to propose 340B legislation.
Read More